GlobeNewswire Inc.··NaLifeward Shareholders Back Oramed Partnership to Diversify Into Biotech
Lifeward gains shareholder approval for strategic Oramed deal, securing up to $47M capital while expanding into oral delivery technology.
LFWDORMPstrategic partnershipclinical development